+ All Categories
Home > Documents > Session 1 - Introduction (1)

Session 1 - Introduction (1)

Date post: 04-Jun-2018
Category:
Upload: pranay-madan
View: 216 times
Download: 0 times
Share this document with a friend

of 33

Transcript
  • 8/13/2019 Session 1 - Introduction (1)

    1/33

    Bioscience Strategy

    ALS 354

    Dr. Jay Chok

    Professor of Entrepreneurship and Strategy

  • 8/13/2019 Session 1 - Introduction (1)

    2/33

    Introduction

  • 8/13/2019 Session 1 - Introduction (1)

    3/33

    Jay and his family

  • 8/13/2019 Session 1 - Introduction (1)

    4/33

  • 8/13/2019 Session 1 - Introduction (1)

    5/33

    External

    Choice of industry

    Geographic location

    (nation / region)

    Period in history

    Internal

    Firms capabilities

    Firms reputation / brand

    Firms leadership /

    culture

    Examples of internal and external factors

  • 8/13/2019 Session 1 - Introduction (1)

    6/33

    How to know that you have a

    functioning strategy?

  • 8/13/2019 Session 1 - Introduction (1)

    7/33

  • 8/13/2019 Session 1 - Introduction (1)

    8/33

    Having a formula for being

    above average consistently is

    really hard!

  • 8/13/2019 Session 1 - Introduction (1)

    9/33

    Having a formula for being above

    average consistently is really hard!

    Change in Forbes 100 List Over 70 Years

    -80

    -40

    0

    40

    80

    120

    1917 1987

    New FirmsOriginal

    100

    Firms

    49 Failures

    18 Survivors

  • 8/13/2019 Session 1 - Introduction (1)

    10/33

    Why are successful,

    enduring strategies rare?

    Problem Other people are just as smart as you are.

    The world changes, so no one formula lasts

    forever. Implications

    Formula is simple: Others will eventually

    follow. Formula is complex: You may have just

    gotten lucky. Luck wont save you when the

    world changes.

  • 8/13/2019 Session 1 - Introduction (1)

    11/33

    Why have a strategy course?

  • 8/13/2019 Session 1 - Introduction (1)

    12/33

  • 8/13/2019 Session 1 - Introduction (1)

    13/33

    Learn strategy to deal with challenges

    presented by Life-science Industries

    High degree of uncertainty in product development

    Requires integration of various types of knowledge

    Knowledge is tacit (i.e. hard to share)

    Public policy environment

    Regulatory environment

    Is healthcare a product or a right?

  • 8/13/2019 Session 1 - Introduction (1)

    14/33

    Course Goals

    Develop the perspective of a general manager and

    identify strategic issues commensurate with this

    perspective.

    Strengthen your ability to present your strategicarguments in a persuasive manner.

    Develop diagnostic reasoning skills that will help

    you determine appropriate courses of strategic

    action.

    Foster teamwork & professionalism

    G l M

  • 8/13/2019 Session 1 - Introduction (1)

    15/33

    General Management

    Perspective

    1. Pay attention to institutional changes in the

    markets that matter to you

    Rules of the game: formal rules, norms, best or

    custom practices, and beliefs

    E.g. Managed care & Waxman-Hatch change

    how Big Pharma compete

    E.g. AHS took advantage of off-shoring trends inUSA healthcare markets & EHR mandate

    E.g. Teva took advantage of Waxman-Hatch to

    compete in USA

    G l M t

  • 8/13/2019 Session 1 - Introduction (1)

    16/33

    General Management

    Perspective

    2.Balance between short-term & long-term

    perspective

    3.Often intertwined with balance between old

    and new products or markets

    E.g. Due to limited resources, AHS had to

    decide how to balance betn

    new service offerings in USA

    adapting existing service offerings to sell in other

    geographic markets

    G l M t

  • 8/13/2019 Session 1 - Introduction (1)

    17/33

    How should Teva balance old & new?

    Corporate culture for blockbuster (new) differs from that

    of generics (old)

    If units are kept separate, why not spin off generic orinnovative?

    With limited resources, how can Teva structure

    innovative projects to take advantage of strategic

    relationships? Israel academic scientists & marketing partner

    General Management

    Perspective

    G l M t

  • 8/13/2019 Session 1 - Introduction (1)

    18/33

    Should Teva focus mainly on generics or move

    up the value chain?

    Generics have reliable returns now but subject to

    imitation in future

    Blockbuster & biosimilars are more risky now but

    may have bigger payoffs in future

    Risk profits for multiple quarters or years butdont bet the farm

    General Management

    Perspective

  • 8/13/2019 Session 1 - Introduction (1)

    19/33

    Diagnostic Reasoning Skills and the Case

    Method

    Diagnostic reasoning is the ability to quickly seerelationships between apparently unrelated pieces of

    data, leaping to appropriate conclusions without a linear

    approach.

    The general manager needs business judgment, i.e.

    wisdom

    Too much data, not enough information.

    Too little time.

    This course is designed to help you past the beginner

    stage of experiential learning through cases.

  • 8/13/2019 Session 1 - Introduction (1)

    20/33

    How to prepare a case

    Skim contents quickly

    Quick reading (30 minutes)

    Reflection (10 minutes)

    What issues do you think may be relevant for

    discussion? What information would you like to have to confirm

    your hunches?

    Review preparation questions (10 minutes)

    Update your list of issues to investigate andinformation that you like to have.

    [Sometimes relevant] Review any co-assigned or past text

    excerpts, articles or lectures that you think might be

    relevant. (20 minutes)

  • 8/13/2019 Session 1 - Introduction (1)

    21/33

    How to prepare a case

    Analysis (1 hour) Review case to uncover the answers to your questions and to

    validate / invalidate your hunches / hypotheses.

    Includes qualitative and quantitative analysis.

    Prepare your findings for presentation (20 minutes)

    Summarize your conclusions.

    For each conclusion, document supporting information that could

    be shared in a concise manner.

    Talk over your findings with a peer or a group before class. (1015

    minutes)

    Total Time: 2.53 hours

  • 8/13/2019 Session 1 - Introduction (1)

    22/33

    How to succeed in this course

    Pursue right thinking more than right answers.

    Come fully prepared for each class.

    But dont stop there! Let your thinking evolve

    during each class! Make connections across cases and sessions

    whenever possible.

    Be able to explain strategic frameworks &

    concepts in your own words.

    Seek help early when you dont understand the

    material.

  • 8/13/2019 Session 1 - Introduction (1)

    23/33

    Other

    Review key items from syllabus (esp. code

    of conduct)

    Examples of unacceptable behavior:

    Arriving late for class meetings or leaving early.

    Inattention during class meetings.

    Disrespectful comments or unprofessional

    language.

    Sakai

    Minapsys

  • 8/13/2019 Session 1 - Introduction (1)

    24/33

    10-minute break

  • 8/13/2019 Session 1 - Introduction (1)

    25/33

    Industry Analyses

  • 8/13/2019 Session 1 - Introduction (1)

    26/33

    IO View

    Industrial-Organizational View

    Structure-Conduct-Performance Paradigm

    Industry Structure dictates firm Conduct whichdetermines firm Performance

    Focuses on the industryas the primary driver

    of strategy

    Assumption: resources to implement strategiesare perfectly replicable

    GOAL: Locate in most attractive industry

  • 8/13/2019 Session 1 - Introduction (1)

    27/33

    Above Average

    Returns(in Excess of the Competitive Level)

    Avoid

    Competition

    Attractive Industry

    Entry

    Barriers

    Low

    RivalryPower over

    customers &

    suppliers

    But rivalsresponse

    could render

    industry

    unattractivefor entry

    (Insights from

    Game Theory

    lecture &cases)

  • 8/13/2019 Session 1 - Introduction (1)

    28/33

    Components of Industry Profitability and

    Our Toolkit for Analysis

    Industry

    Profitability= Value Creation x Value Capture

    Demand createdCost of Inputs

    Ability toappropriate rewards

    ConceptDefined

    PIE Chart

    (Potential Industry Earnings)

    Porter Five-ForcesCorrespondingTool

  • 8/13/2019 Session 1 - Introduction (1)

    29/33

    Value Capture Factors

    Factors

    Buyer Power

    Supplier Power

    Threat of entry

    Rivalry amongst

    incumbents

    Industry output

    Industry

    Price

    Level

    Supplier

    Mark-up

    Buyers

    Incumbents

    Suppliers

    Quantity

    Price

  • 8/13/2019 Session 1 - Introduction (1)

    30/33

    $

    Porter 5-Forces Analysis

    Rivalry amongIncumbents Buyer Power

    Supplier Power

    Substitutes

    Threat ofEntrants

  • 8/13/2019 Session 1 - Introduction (1)

    31/33

    Pharmaceutical Industry Exercise

    Pick 3 out of 7 options for Big Pharma. Compare

    and contrast the 3 options, evaluating the potential

    pros and cons.

    Be prepared to explain/defend your logic in the next class

    Form small groups outside the classroom. Discuss your

    arguments. Try to reach a consensus agreement on the

    answer and the logic behind it.

    Y b lik

  • 8/13/2019 Session 1 - Introduction (1)

    32/33

    Yes, you are super-busy like

    Superman but remember to

    Be iClickers ready

    Prepare Thursday cases

    on Tuesday evening or

    by Wednesday noon Finish Minapsys

    questions by 5pm on

    Wednesdays

    Form self-study groups

    (Encouraged)

  • 8/13/2019 Session 1 - Introduction (1)

    33/33

    See you on Thursday


Recommended